Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Ulcerative Colitis (UC) Clinical Trials

25 recruiting trials for Ulcerative Colitis (UC). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
25
Total Trials
25
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT06862843

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic...

The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting...

Sponsor: Meyer Children's Hospital IRCCSEnrolling: 904 locations
RECRUITINGNCT05414578

NORDTREAT Prospective Study on Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and which may severely...

Sponsor: University of Southern DenmarkEnrolling: 80017 locations
RECRUITINGNCT06756100

Early Inflammatory Bowel Disease Progression

The purpose of this study is to assess the capacity of the gut microbial composition and function to predict the course of IBD during the first year after diagnosis.

Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 1401 location
RECRUITINGNCT06698601

Wild Blueberries in Colitis

The goal of this exploratory, prospective, monocentric randomized crossover study is to investigate the influence of a blueberry-rich diet compared to a blueberry-poor diet on the...

Sponsor: Universität Duisburg-EssenEnrolling: 601 location
RECRUITINGNCT07013578

TIDHI Mental Health in IBD Patients Study

The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly...

Sponsor: TIDHI Innovation Inc.Enrolling: 1001 location
RECRUITINGNCT07237516

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

The goal of this observational study is to learn about how effective Zymfentra (IFX=dyyb) is when treating patients with Crohn's disease (CD) and ulcerative colitis (UC) Does...

Sponsor: University of North Carolina, Chapel HillEnrolling: 2005 locations
RECRUITINGNCT01277419

German Spondyloarthritis Inception Cohort

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA...

Sponsor: Charite University, Berlin, GermanyEnrolling: 10001 location
RECRUITINGNCT07141238

Microplastic Analysis in Pediatric Inflammatory Bowel Disease

The goal of this observational study is to measure and compare the presence of microplastics in children with inflammatory bowel disease (IBD) and children without IBD. The main...

Sponsor: Medical University of GdanskEnrolling: 401 location
RECRUITINGNCT05377840

Use of Psychologist-administered Cognitive Behavioral Therapy (CBT) or Self-administered CBT for the Treatment of...

This is a prospective, single center, randomized treatment study to assess if anxiety and depression in participants with IBD can be improved with CBT compared to those treated...

Sponsor: Yale UniversityEnrolling: 1521 location
RECRUITINGPhase 2NCT06604260

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

Our main objective is to evaluate the feasibility of 68Ga-FAPi PET/CT in detecting intestinal fibrosis in patients with IBD. To this end, we will determine 68Ga-FAPi uptake in IBD...

Sponsor: Dalia LarteyEnrolling: 201 location
RECRUITINGNCT07245394

Switching to the IL-23 Inhibitor Guselkumab for People With Active IBD Who Previously Used Ustekinumab (SHIFT-IBD)

The SHIFT-IBD Study is being conducted at multiple medical centers across Canada to evaluate how well guselkumab (Tremfya) works for people with inflammatory bowel disease (IBD)...

Sponsor: TIDHI Innovation Inc.Enrolling: 2009 locations
RECRUITINGNCT07319442

CEDUR - German IBD Registry

The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity,...

Sponsor: ImmunoRegister gUGEnrolling: 100001 location
RECRUITINGNCT06773182

Assessing Interventions of Diet in IBD

In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to...

Sponsor: McMaster UniversityEnrolling: 453 locations
RECRUITINGNCT06693310

STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission

The goal of this study is to better understand treatment strategies for people with ulcerative colitis (UC). Researchers will compare patients with UC in histologic remission (no...

Sponsor: University of ChicagoEnrolling: 2001 location
RECRUITINGNCT06895252

A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Newly...

Ulcerative colitis (UC) is a chronic inflammatory condition affecting the colon and rectum, characterized by mucosal inflammation and symptomslike diarrhea, abdominal pain, and...

Sponsor: All India Institute of Medical SciencesEnrolling: 2206 locations
RECRUITINGPhase 2NCT06850727

Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative...

The purpose of this study is to evaluate the clinical efficacy and safety of OD-07656 in participants with moderately to severely active ulcerative colitis (UC). In addition, the...

Sponsor: Odyssey TherapeuticsEnrolling: 5720 locations
RECRUITINGPhase 2NCT07427017

Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies

Micronutrient deficiencies are common in ulcerative colitis (UC). Selenium deficiency is associated with worse disease outcomes including disease flares and need for surgery....

Sponsor: Northwestern UniversityEnrolling: 1801 location
RECRUITINGNCT07442045

Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in...

This multicenter retrospective cohort study evaluates the real-world effectiveness and safety of upadacitinib used alone or in combination with vedolizumab in adult patients with...

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen UniversityEnrolling: 1501 location
RECRUITINGNCT06095596

Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis

It's of great importance to effectively induce and maintain disease remission in patients with moderate to severe ulcerative colitis (UC). Vedolizumab (VDZ) is known for its high...

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen UniversityEnrolling: 3341 location
RECRUITINGNCT06962020

Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

The purpose of this prospective, multicenter, real-world study is to compare the efficacy differences and influencing factors of different first-line biologics in patients with...

Sponsor: Xijing Hospital of Digestive DiseasesEnrolling: 4001 location
RECRUITINGPhase 2NCT07335055

A Study for HSK47388 in Participants With Ulcerative Colitis

The purpose of this protocol is to evaluate the efficacy and safety of HSK47388 as therapy in participants with moderately to severely active ulcerative colitis .

Sponsor: Haisco Pharmaceutical Group Co., Ltd.Enrolling: 1501 location
RECRUITINGPhase 2NCT07333716

Desloratadine in Patients With Ulcerative Colitis

The purpose of this study is to investigate safety and therapeutic efficacy of antihistamine (desloratadine) on inflammation and disease activity when administered as adjuvant...

Sponsor: Tanta UniversityEnrolling: 441 location
RECRUITINGNCT06067698

Alpha Lipoic Acid in Ulcerative Colitis

This study aims at evaluating the efficacy and safety of alpha-lipoic acid as adjuvant therapy to mesalamine in patients with mild to moderate ulcerative colitis due to its effect...

Sponsor: Tanta UniversityEnrolling: 601 location
RECRUITINGPhase 2NCT07113522

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study...

Sponsor: Mirador Therapeutics, Inc.Enrolling: 14020 locations
RECRUITINGNCT07046468

Smart Pill for Measuring Gut Health in Colon Inflammation and Colon Cancer

The goal of this observational pilot study with invasive measurements is to explore whether an ingestible sensor pill can be of use in diagnosis or monitoring of disease in...

Sponsor: Radboud University Medical CenterEnrolling: 101 location

Frequently Asked Questions

There are currently 25 clinical trials for Ulcerative Colitis (UC), with 25 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Ulcerative Colitis (UC), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Ulcerative Colitis (UC), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice — always talk to your doctor about clinical trial participation.